Interaction of benzo[a]pyrene with other risk factors in hepatocellular carcinoma: A case-control study in Xiamen, China

Annals of Epidemiology

Volumn 24, Issue 2, 2014, Pages 98-103

  Su, Yanhua ^a   Zhao, Benhua ^a   Guo, Fei ^a   Bin, Zhao ^a   Yang, Yue ^a   Liu, Sheng ^a   Han, Yaofeng ^a   Niu, Jianjun ^b   Ke, Xiayi ^c   Wang, Ning ^d   Geng, Xuesi ^e   Jin, Changnan ^e   Dai, Yichen ^f   Lin, Yuanyuan ^f  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Center for Disease Control and Prevention   (China)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^e Xiamen Hospital of Traditional Chinese Medicine   (China)

^f 174th Hospital of People's Liberation Army   (China)

Author keywords

Benzo a pyrene; Case control study; DNA adduct; Hepatocellular carcinoma; Risk factor

Indexed keywords

BENZO[A]PYRENE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARCINOGEN DNA INTERACTION; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIVORCE; DNA ADDUCT; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCOME; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SINGLE (MARITAL STATUS); SMOKING; WIDOW;

BENZO[A]PYRENE; CASE-CONTROL STUDY; DNA ADDUCT; HEPATOCELLULAR CARCINOMA; RISK FACTOR;

ADULT; AGED; BENZO(A)PYRENE; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; DNA ADDUCTS; ENVIRONMENTAL POLLUTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84892955631     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.10.019     Document Type: Article

References (41)

1. Yeh F.S., Yu M.C., Mo C.C., Luo S., Tong M.J., Henderson B.E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989, 49:2506-2509.
2. Chen W., Zheng R., Zhang S., Zhao P., Li G., Wu L., et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 2013, 25:10-21.
3. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
4. Chen C.J., Liang K.Y., Chang A.S., Chang Y.C., Lu S.N., Liaw Y.F., et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991, 13:398-406.
5. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Amer J Epidemiol 2002, 155:323-331.
6. Hassan M.M., Spitz M.R., Thomas M.B., El-Deeb A.S., Glover K.Y., Nguyen N.T., et al. Effect of different types of smoking and synergism with Hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 2008, 123:1883-1891.
7. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect 2010, 118:818-824.
8. Yu M.W., Chen C.J. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994, 17:71-91.
9. Li F.Q., Yoshizawa T., Kawamura O., Luo X.Y., Li Y.W. Aflatoxins and fumonisins in corn from the high-incidence area for human hepatocellular carcinoma in Guangxi, China. J Agric Food Chem 2001, 49:4122-4126.
10. Wang J., Liu X.M. Contamination of aflatoxins in different kinds of foods in China. Biomed Environ.Sci 2007, 20:483-487.
11. Wang J.S., Huang T., Su J., Liang F., Wei Z., Liang Y., et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarker Prev 2001, 10:143-146.
12. Wang L.Y., Hatch M., Chen C.J., Levin B., You S.L., Lu S.N., et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996, 67:620-625.
13. Qian G.S., Ross R.K., Yu M.C., Yuan J.M., Gao Y.T., Henderson B.E., et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994, 3:3-10.
14. Szymanska K., Chen J.G., Cui Y., Gong Y.Y., Turner P.C., Villar S., et al. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China. Cancer Epidemiol Biomarkers Prev 2009, 18:1638-1643.
15. Wu H.C., Wang Q., Yang H.I., Ahsan H., Tsai W.Y., Wang L.Y., et al. Urinary 15-F-2t-isoprostane, aflatoxin B-1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 2008, 29:971-976.
16. Groopman J.D., Johnson D., Kensler T.W. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. Cancer Biomark 2005, 1:5-14.
17. Qu C.X., Kamangar F., Fan J.H., Yu B., Sun X.D., Taylor P.R., et al. Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. J Natl Cancer Inst 2007, 99:1240-1247.
18. Welzel T.M., Katki H.A., Sakoda L.C., Evans A.A., London W.T., Chen G., et al. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort. Cancer. Epidemiol. Biomarkers Prev 2007, 16:1279-1282.
19. McGlynn K.A., London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005, 19:3-23.
20. Wu H.C., Wang Q., Wang L.W., Yang H.I., Ahsan H., Tsai W.Y., et al. Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Lett 2007, 252:104-114.
21. ATSDR. Toxicological profile for toxicological profile for polycyclic aromatic hydrocarbons. 1995. http://www.atsdr.cdc.gov/toxprofiles/tp35.pdf.
22. Zhou G.D., Richardson M., Fazili I.S., Wang J., Donnelly K.C., Wang F., Amendt B., et al. Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: implications for cancer prevention. Toxicol Appl Pharmacol 2010, 249:224-230.
23. Chen S.Y., Wang L.Y., Lunn R.M., Tsai W.Y., Lee P.H., Lee C.S., et al. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer 2002, 99:14-21.
24. Zhang Y.J., Rossner P., Chen Y., Agrawal M., Wang Q., Wang L., et al. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int J Cancer 2006, 119:985-991.
25. Rundle A., Schnabel F., Kelly A., Levine R., et al. Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Environ Mol Mutagen 2002, 39:201-207.
26. Tang D., Santella R.M., Blackwood A.M., Young T.L., Mayer J., Jaretzki A., et al. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev 1995, 4:341-346.
27. Tang D., Phillips D.H., Stampfer M., Mooney L.A., Hsu Y., Cho S., et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 2001, 61:6708-6712.
28. Veglia F., Matullo G., Vineis P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003, 12:157-160.
29. Perera F.P., Hemminki K., Young T.L., Brenner D., Kelly G., Santella R.M. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res 1988, 48:2288-2291.
30. Gammon M.D., Santella R.M., Neugut A.I., Eng S.M., Teitelbaum S.L., Paykin A., et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemio Biomarkers Prev 2002, 11:677-685.
31. Johnson N.M., Qian G., Xu L., Tietze D., Marroquin-Cardona A., Robinson A., et al. Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci Total Environ 2010, 408:6027-6031.
32. Thyssen J., Althoff J., Kimmerle G., Mohr U. Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J Natl Cancer Inst 1981, 66:575-577.
33. Autrup H., Vestergaard A.B., Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in nonsmoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 1995, 16:1305-1309.
34. Tang D., Warburton D., Tannenbaum S.R., Skipper P., Santella R.M., Cereijido G.S., et al. Molecular and genetic damage from environmental tobacco smoke in young children. Cancer Epidemiol Biomarkers Prev 1999, 8:427-431.
35. Autrup H., Daneshvar B., Dragsted L.O., Gamborg M., Hansen M., Loft S., et al. Biomarkers for exposure to ambient air pollution-comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ Health Perspect 1999, 107:233-238.
36. Godschalk R.W., Van Schooten F.J., Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 2003, 36:1-11.
37. Godschal R., Nair J., van Schooten F.J., Risch A., Drings P., Kayser K., et al. Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. Carcinogenesis 2002, 23:2081-2086.
38. Poirier M.C. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ Health Perspect 1997, 105:907-912.
39. Rothman N., Correa-Villaseñor A., Ford D.P., Poirier M.C., Haas R., Hansen J.A., et al. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol Biomarkers Prev 1993, 2:341-347.
40. Purohit V., Rapaka R., Kwon O.S., Song B.J. Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sci 2013, 92:3-9.
41. Boffetta P., Hashibe M., La Vecchia C., Zatonski W., Rehm J. The burden of cancer attributable to alcohol drinking. In J Cancer 2006, 119:884-887.